동영상
블로그
- Myongji Hospital, Macrogen agree on genome information-based disease management Myongji Hospital, Macrogen agree on genome information-based disease management ▲Macrogen CEO Suh Jeong-sun two sides are expected to cooperate with clinical trials of chemotherapeutic treatment such as anti-cancer
- 조티펜스 2019.10.18 페이스북 최신후기 Her husband is bad off with cancer and chemo is doing him in, so to speak. She has completely ignored my sentiment or even the information.
- Gastric Cancer News Gastric Cancer News Sutent® Approved by FDA for Treatment of Renal Cell Carcinoma and Gastrointestinal A patient information sheet has been published on the FDA Web site.[1] Sutent is an oral kinase inhibitor

